LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly
NORWALK, Conn., Sept. 24, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration with Eli Lilly and Company ("Lilly") focused on advancing innovative gene therapies for Type 2 diabetes and obesity. This partnership underscores...
TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion
BOSTON, Sept. 24, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced powerful new capabilities in its Orchestration Platform for Universal Solutions (OPUS) designed to unlock unprecedented productivity. These enhancements enable finance, commercial, and IT teams to radically improve agility and...
LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services
JOHNSON CITY, Tenn., Sept. 23, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, announces a strategic collaboration with The Bracken Group to enhance its radiopharmaceutical support capabilities. As demand for radiopharmaceutical expertise continues to surge, with industry growth estimated between 15% and 20%...
Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge
FDA registration fulfills requirements for U.S. market entry Initial shipments to Europe and Latin America to begin with pre-approved countries YONGIN, South Korea, Sept. 23, 2025 /PRNewswire/ -- Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced that FDA registration has been completed...
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions
CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ -- Pictor Holdings Inc., a global leader in targeted, multiplex proteomics, today announced the close of a convertible note funding round led by existing investors. The raise underscores strong confidence in Pictor's strategic expansion and recent establishment of its U.S. headquarters in Carlsbad, California. The convertible...
Kemin Industries Acquires CJ Bio Subsidiary CJ Youtell Biotech
Specializing in enzymes and fermentation, the biotech company will transform the expansion of Kemin's global enzyme production capabilities DES MOINES, Iowa and SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its...
HKeyBio Lauched the Most Comprehesive Non-human Primate Autoimmune & Allergic Disease Model Matrix to Redefining Clinical Translation
BOSTON and SUZHOU, China, Sept. 23, 2025 /PRNewswire/ -- HKeyBio, a CRO specializing in preclinical and translational autoimmune-drug development, today announced the launch of HKEY-NHP-MATRIX2.0, a next-generation platform designed to improve the reliability of translating novel autoimmune and allergy therapies from preclinical research to clinical success. Platform Highlights Broad Primate Disease Model LibraryThe platform includes over twenty non-human...
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test....
Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress
CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- The 2025 European Society for Medical Oncology (ESMO) Congress will take place in Berlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) will present results from multiple clinical studies at the congress, including data from its TROP2 ADC sacituzumab...
Mindray Unveils Project 2030 and Re-writes the Future of Women’s Health Ultrasound at ISUOG
CANCUN, Mexico, Sept. 23, 2025 /PRNewswire/ -- On September 15th, at ISUOG 2025 World Congress in Cancun, Mexico, Mindray unveiled Project 2030, an initiative to improve global access to ultrasound technology. The project was launched to an international audience of leading specialists, capping a conference that featured Mindray's OBG solutions as a key highlight. Mindray's Women Healthcare...
